Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Response Biomedical
UK Identifies First Recipients Of Future COVID-19 Vaccine
As clinical trials of potential coronavirus vaccines continue, the UK government has drawn up a list of those who should be first in line for vaccination, although it cautions that many unknowns remain in areas such as efficacy, dosing schedules and duration of protection.
Keeping Track: Clarus, Agile and Sunovion Look To Bounce Back From CRLs; FDA To Review Rituximab Biosimilar
The latest drug development news and highlights from our US FDA Performance Tracker.
Will New CEOs Make C-Suite More 'She-Suite'?
Improving gender balance in top pharma is a slow process, but not a gradual one. Management shake-ups often implemented by newly appointed CEOs could help.
EpiPen Familiarity May Prove Tough Hurdle For Generics
With EpiPen injector patent-protected and patients accustomed to its use, finding a substitutable generic device may prove difficult.
- In Vitro Diagnostics
- Diagnostic Equipment & Supplies
- Other Names / Subsidiaries
- 1077801 B.C. Ltd.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.